相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multinucleation and Mesenchymal-to-Epithelial Transition Alleviate Resistance to Combined Cabazitaxel and Antiandrogen Therapy in Advanced Prostate Cancer
Sarah K. Martin et al.
CANCER RESEARCH (2016)
αvβ6 integrin is required for TGFβ1-mediated matrix metalloproteinase2 expression
Anindita Dutta et al.
BIOCHEMICAL JOURNAL (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer
Robert J. van Soest et al.
EUROPEAN UROLOGY (2015)
Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies
Nader Al Nakouzi et al.
EUROPEAN UROLOGY (2015)
Therapy-induced tumour secretomes promote resistance and tumour progression
Anna C. Obenauf et al.
NATURE (2015)
Androgen receptor splice variants circumvent AR blockade by microtubule-targeting agents
Guanyi Zhang et al.
ONCOTARGET (2015)
Cofilin Drives Cell-Invasive and Metastatic Responses to TGF-β in Prostate Cancer
Joanne Collazo et al.
CANCER RESEARCH (2014)
Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
Barbara Kahn et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer
Ping Li et al.
MOLECULAR CANCER (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy REPLY
Tomasz M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
T. M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Expression patterns of epithelial-mesenchymal transition markers in localized prostate cancer: significance in clinicopathological outcomes following radical prostatectomy
Hosny M. Behnsawy et al.
BJU INTERNATIONAL (2013)
The Steroid Receptor Coactivator-3 Is Required for the Development of Castration-Resistant Prostate Cancer
Jean C-Y. Tien et al.
CANCER RESEARCH (2013)
Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Yuting Sun et al.
CANCER RESEARCH (2012)
Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells
David J. Mulholland et al.
CANCER RESEARCH (2012)
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Karim Fizazi et al.
LANCET ONCOLOGY (2012)
Vav3 Enhances Androgen Receptor Splice Variant Activity and Is Critical for Castration-Resistant Prostate Cancer Growth and Survival
Stephanie O. Peacock et al.
MOLECULAR ENDOCRINOLOGY (2012)
Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1
Changmeng Cai et al.
CANCER CELL (2011)
Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer
Medha S. Darshan et al.
CANCER RESEARCH (2011)
An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition
Philip A. Gregory et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
Androgen regulation of epithelial-mesenchymal transition in prostate tumorigenesis
Emily A. Matuszak et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2011)
An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
Jindan Yu et al.
CANCER CELL (2010)
Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
Meng-Lei Zhu et al.
CANCER RESEARCH (2010)
Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells
Meng-Lei Zhu et al.
FASEB JOURNAL (2010)
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
Hiroshi Tanaka et al.
NATURE MEDICINE (2010)
Dysfunctional Transforming Growth Factor-β Receptor II Accelerates Prostate Tumorigenesis in the TRAMP Mouse Model
Hong Pu et al.
CANCER RESEARCH (2009)
TGF-β signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer
Meng-Lei Zhu et al.
PROSTATE (2008)
Interaction between smad7 and β-catenin:: Importance for transforming growth factor β-induced apoptosis
S Edlund et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Development of TGF-β signalling inhibitors for cancer therapy
JM Yingling et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Recruitment of β-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells
D Masiello et al.
MOLECULAR ENDOCRINOLOGY (2004)
Androgen receptor gene amplification and protein expression in recurrent prostate cancer
OH Ford et al.
JOURNAL OF UROLOGY (2003)
分享论文
